Science Explorer Back to mapMap
Discussion
Topic · Pulmonary and Respiratory Medicine

Inhalation and Respiratory Drug Delivery

Inhalation and Respiratory Drug Delivery is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 34k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on advancements in pulmonary drug delivery techniques, including the use of inhaler devices, nanoparticles, aerosol therapy, and dry powder inhalers. It explores topics such as respiratory tract deposition, lung diseases, nanomedicine, and the delivery of inhaled insulin.

  • Pulmonary Drug Delivery
  • Inhaler Devices
  • Nanoparticles
  • Aerosol Therapy
  • Particle Engineering
  • Respiratory Tract Deposition
  • Dry Powder Inhalers
  • Lung Diseases
  • Nanomedicine
  • Inhaled Insulin
Research works
34k
fractional, since 1950
In the world top 10%
3.4k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+16%
the tick is no change
Largest producer
United States
31% of the 10 largest, 2022-now
Inhalation and Respiratory Drug Delivery

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Inhalation and Respiratory Drug Delivery research?

By volume, the United States and China publish the most (1.3k and 796 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.3k works
  2. 2 China 796 works
  3. 3 India 489 works
  4. 4 United Kingdom 409 works
  5. 5 Germany 259 works
  6. 6 Italy 215 works
  7. 7 Canada 190 works
  8. 8 Japan 182 works
  9. 9 France 177 works
  10. 10 Spain 153 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 31.0%China: 19.1%India: 11.8%United Kingdom: 9.8%6 others listed: 28.2%31%largest
United States1,292 · 31.0%China796 · 19.1%India489 · 11.8%United Kingdom409 · 9.8%6 others listed1,175 · 28.2%

Shares of the rows listed above, not of the whole node.

Which institutions lead Inhalation and Respiratory Drug Delivery research?

By volume in 2022-now, Harvard University publishes the most Inhalation and Respiratory Drug Delivery research, followed by University of North Carolina at Chapel Hill and AstraZeneca (United Kingdom).

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 48 works
  2. 2 University of North Carolina at Chapel HillUnited States 42 works
  3. 3 AstraZeneca (United Kingdom)United Kingdom 40 works
  4. 4 Centre National de la Recherche ScientifiqueFrance 33 works
  5. 5 Sichuan UniversityChina 27 works
  6. 6 Chinese Academy of SciencesChina 27 works
  7. 7 Imperial College LondonUnited Kingdom 26 works
  8. 8 University of GroningenNetherlands 24 works
  9. 9 InsermFrance 22 works
  10. 10 The University of SydneyAustralia 19 works

Who are the leading researchers in Inhalation and Respiratory Drug Delivery?

The most-cited researchers publishing on Inhalation and Respiratory Drug Delivery include George Davey Smith, Gordon Henry Guyatt and Róbert Langer.

  1. 1 George Davey Smith United Kingdom 435k citations
  2. 2 Gordon Henry Guyatt Canada 315k citations
  3. 3 Róbert Langer United States 303k citations
  4. 4 Wei Huang China 267k citations
  5. 5 Jean‐Louis Vincent Belgium 262k citations
  6. 6 Ben Zhong Tang China 261k citations
  7. 7 Hans C. Clevers Netherlands 260k citations
  8. 8 Amirhossein Sahebkar Iran 258k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Inhalation and Respiratory Drug Delivery?

The most cited paper in Inhalation and Respiratory Drug Delivery is "Drug delivery and nanoparticles: Applications and hazards" (de Jong, 2008), with 3,853 citations. Next come "Table of Integrals, Series, and Products" (3,295) and "Global strategy for asthma management and prevention: GINA executive summary" (3,258).

Most cited papers
#PaperReleasedCitations
1 Drug delivery and nanoparticles: Applications and hazards de Jong · International Journal of Nanomedicine Open access Jun 2008 3,853
2 Table of Integrals, Series, and Products I. S. Gradshteyn, I. M. Ryzhik, Alan Jeffrey et al. · Journal of Biomechanical Engineering Open access Feb 1981 3,295
3 Global strategy for asthma management and prevention: GINA executive summary Eric Donn Bateman, Suzanne S. Hurd, Peter John Barnes et al. · European Respiratory Journal Open access 31 Dec 2007 3,258
4 Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release Nazila Kamaly, Basit Yameen, Jun Hua Wu et al. · Chemical Reviews ReviewOpen access 8 Feb 2016 3,033
5 Development of the asthma control test Robert A. Nathan, Christine A. Sorkness, Mark R. Kosinski et al. · Journal of Allergy and Clinical Immunology 2004 2,939
All 98 most cited papers, with filters and sorting

Where is Inhalation and Respiratory Drug Delivery research done?

The largest centres of Inhalation and Respiratory Drug Delivery research in 2022-now are London (United Kingdom), Beijing (China), Shanghai (China) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Parma.

Largest cities, 2022-now

  1. 1 LondonUnited Kingdom 125 works
  2. 2 BeijingChina 109 works
  3. 3 ShanghaiChina 70 works
  4. 4 GuangzhouChina 69 works
  5. 5 ParisFrance 63 works
  6. 6 SeoulSouth Korea 62 works
  7. 7 BostonUnited States 54 works
  8. 8 SydneyAustralia 53 works
  9. 9 TokyoJapan 49 works
  10. 10 MoscowRussia 48 works

Where it is the local speciality

  1. ParmaIT · 28.4 works17×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Inhalation and Respiratory Drug Delivery than the world average.

See Inhalation and Respiratory Drug Delivery on the map

Where is the best place to study Inhalation and Respiratory Drug Delivery?

Among universities, judged by research, Harvard University, University of Leicester and Soochow University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 20.14%fractional works in this field (log) →share of work in the world top 10% →Soochow UniversityUniversity of Leices…University of Britis…Harvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 71.612.0%2.8×48 +45.2%
2University of LeicesterUnited Kingdom 70.930.3%8.9×13 +189.1%
3Soochow UniversityChina 65.230.7%2.6×14 +162.9%
4University of British ColumbiaCanada 64.219.1%2.7×18 +21.3%
5Sichuan UniversityChina 64.021.2%2.3×27 +87.5%
6University of GroningenNetherlands 63.811.5%6.7×24 +13.1%
7Shenyang Pharmaceutical UniversityChina 62.726.1%20.2×14 +14.0%
8Macquarie UniversityAustralia 60.113.6%8.6×17 +30.6%
9Zhejiang UniversityChina 59.128.4%1.1×15 +32.0%
10Imperial College LondonUnited Kingdom 57.48.5%5.0×26 +0.5%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Inhalation and Respiratory Drug Delivery, country by country

Is Inhalation and Respiratory Drug Delivery research growing?

Output in 2022-2025 was 16% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Inhalation and Respiratory Drug Delivery.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Inhalation and Respiratory Drug Delivery as a percentage of every work published that year, 0.024% in 2024.

still counting0.025%0.050%0.075%Inhalation and Respiratory Drug Delivery0.026% in 202519801990200020102020

Fractional works of Inhalation and Respiratory Drug Delivery over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Inhalation and Respiratory Drug Delivery10.3% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Inhalation and Respiratory Drug Delivery. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.